Jefferies Group’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $362K | Hold |
9,250
| – | – | ﹤0.01% | 749 |
|
|
2022
Q2 | $299K | Buy |
9,250
+4,750
| +106% | +$153K | ﹤0.01% | 737 |
|
|
2022
Q1 | $149K | Buy |
4,500
+1,994
| +80% | +$66K | ﹤0.01% | 843 |
|
|
2021
Q4 | $107K | Sell |
2,506
-1,494
| -37% | -$63.6K | ﹤0.01% | 925 |
|
|
2021
Q3 | $177K | Sell |
4,000
-20,878
| -84% | -$925K | ﹤0.01% | 924 |
|
|
2021
Q2 | $1.41M | Buy |
24,878
+5,878
| +31% | +$334K | 0.01% | 517 |
|
|
2021
Q1 | $1.42M | Buy |
19,000
+1,000
| +6% | +$74.9K | 0.01% | 463 |
|
|
2020
Q4 | $1.56M | Sell |
18,000
-9,500
| -35% | -$822K | 0.01% | 437 |
|
|
2020
Q3 | $1.68M | Sell |
27,500
-7,500
| -21% | -$458K | 0.02% | 350 |
|
|
2020
Q2 | $1.46K | Buy |
35,000
+24,635
| +238% | +$1.02K | 0.02% | 373 |
|
|
2020
Q1 | $298K | Sell |
10,365
-6,253
| -38% | -$180K | ﹤0.01% | 758 |
|
|
2019
Q4 | $1.2M | Buy |
16,618
+3,394
| +26% | +$245K | 0.01% | 712 |
|
|
2019
Q3 | $1.86M | Buy |
13,224
+3,295
| +33% | +$462K | 0.01% | 555 |
|
|
2019
Q2 | $1.82M | Sell |
9,929
-6,571
| -40% | -$1.2M | 0.01% | 472 |
|
|
2019
Q1 | $2.62M | Buy |
16,500
+9,047
| +121% | +$1.44M | 0.02% | 374 |
|
|
2018
Q4 | $714K | Buy |
+7,453
| New | +$714K | 0.01% | 755 |
|
|
2017
Q3 | – | Sell |
-14,000
| Closed | -$1.12M | – | 1734 |
|
|
2017
Q2 | $1.12M | Buy |
+14,000
| New | +$1.12M | 0.01% | 684 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1661 |
|
|
2016
Q4 | – | Sell |
-26,326
| Closed | -$1.21M | – | 1466 |
|
|
2016
Q3 | $1.21M | Sell |
26,326
-16,784
| -39% | -$773K | 0.01% | 513 |
|
|
2016
Q2 | $1.3M | Buy |
+43,110
| New | +$1.3M | 0.01% | 414 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1889 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2494 |
|